Intrinsic Value
Celyad Oncology SA (CYAD.BR)
0.84 €
+0.01 (+1.08%)
| Enterprise Value | - |
|---|---|
| Net Debt | -27.39 |
| Equity Value | - |
| Shares Outstanding | 31.47 |
| Equity Value Per Share | - |
Because investors are more interested in the value of the company’s shares alone, we’ll deduct net debt from this value to arrive at a fair value of the company’s equity. Fair Value = Enterprise Value – Debt